As the airline sector grapples with the second Covid-19 wave, Wadias-promoted GoAir has set its sights on a major expansion drive in terms of network
This follows similar demands by smartphone and laptop makers
India is struggling with a second wave of the pandemic with more than 300,000 new coronavirus cases being reported daily in the past few days
The company expects to build a strong balance sheet in digital business unit which will not just add to the growth of M&M Finance but also help to retain existing customers
After the outbreak of Covid-19, Fractal quickly scaled up efforts to provide empathy towards its staff, customers and vendors. The AI firm is now set to cross $1 bn in revenue
Flexible workforce trend is here to stay, says Apparao V V
The second wave of coronavirus infections reported from various pockets of the country has come as a "strong headwind" to fashion retailers
Hopes to achieve target by April end, is working to rait further
The company has been in discussions with lenders for debt realignment. But lenders are unlikely to approve it without a forensic audit
In addition, ITC is airlifting a large number of oxygen concentrators for distribution, its paperboards unit in Bhadrachalam has commenced supply of oxygen to neighbouring areas
The phase III clinical study, to be conducted in 15 sites across India, will evaluate the immunogenicity and safety of Biological E's vaccine candidate in 1,268 healthy subjects
Sebi rules prescribe that promoters cannot hold more than 75 per cent in a company
Improving exports and a weak rupee could support profit boost
Need for additional towers in question as operators recently added spectrum
After IndiGrid and IRB InvIT fund, this will be the third publicly listed InvIT for the country and the second in the power transmission sector
Firms risk losing talent to more environmentally sustainable peers amid changing consumer sentiment
Company in talks with global and domestic vaccine suppliers
Panasonic set to shut its Jhajjar plant for a week starting Monday
Approval from the drug regulator follows late-stage study of the medicine
Even as 20% of its staff face some kind pandemic stress, the firm has put in place an equal leave policy and level playing field for staff